ALBPS — Biophytis SA Cashflow Statement
0.000.00%
Last trade - 00:00- €0.89m
- €6.48m
Annual cashflow statement for Biophytis SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.8 | -25.5 | -31.2 | -24.2 | -17 |
| Depreciation | |||||
| Non-Cash Items | 1.45 | 11.1 | 7.19 | 4.21 | 2.34 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.808 | 4.44 | -0.052 | 0.54 | 1.01 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -15.3 | -9.74 | -23.8 | -19 | -12.9 |
| Capital Expenditures | -0.282 | -0.214 | -0.344 | -0.141 | -0.22 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.004 | -12.5 | 12.5 | 0.124 | 0.59 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.278 | -12.7 | 12.2 | -0.017 | 0.37 |
| Financing Cash Flow Items | 3.35 | -6.87 | -4.37 | -1.29 | -0.884 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.5 | 22 | 29.7 | 6.13 | 7.03 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -8.07 | -0.49 | 18.1 | -12.9 | -5.49 |